tranexamic acid has been researched along with Coronary Disease in 5 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, SW | 1 |
| Shim, JK | 1 |
| Youn, YN | 1 |
| Song, JW | 1 |
| Yang, SY | 1 |
| Chung, SC | 1 |
| Kwak, YL | 1 |
| Lucas-Polomeni, MM | 1 |
| Delaval, Y | 1 |
| Menestret, P | 1 |
| Delaval, P | 1 |
| Ecoffey, C | 1 |
| Blauhut, B | 1 |
| Harringer, W | 1 |
| Bettelheim, P | 1 |
| Doran, JE | 1 |
| Späth, P | 1 |
| Lundsgaard-Hansen, P | 1 |
| de Bono, DP | 1 |
| More, RS | 1 |
| Casati, V | 1 |
| Gerli, C | 1 |
| Franco, A | 1 |
| Torri, G | 1 |
| D'Angelo, A | 1 |
| Benussi, S | 1 |
| Alfieri, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Tranexamic Acid on Blood Loss and Transfusion Rates in Major Oncologic Surgery[NCT01980355] | 76 participants (Actual) | Interventional | 2012-06-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Surgical blood loss estimation (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | mL (Median) |
|---|---|
| Tranexamic Acid | 450 |
| Placebo | 365 |
To determine the impact of perioperative administration of tranexamic acid on blood loss and transfusion rates in major oncologic surgery (NCT01980355)
Timeframe: From time of surgery to 90 days post hospital discharge
| Intervention | Participants (Count of Participants) |
|---|---|
| Tranexamic Acid | 8 |
| Placebo | 5 |
1 review available for tranexamic acid and Coronary Disease
| Article | Year |
|---|---|
Prevention and management of bleeding complications after thrombolysis.
Topics: Aprotinin; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Drug Interactions; Fibr | 1993 |
3 trials available for tranexamic acid and Coronary Disease
| Article | Year |
|---|---|
Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery.
Topics: Aged; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Comorbidity; Coronar | 2012 |
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.
Topics: Aged; Analysis of Variance; Aprotinin; Blood Coagulation Tests; Blood Loss, Surgical; Cardiopulmonar | 1994 |
Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
Topics: Aged; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease; Double-Blind Method; Drug Ad | 2001 |
1 other study available for tranexamic acid and Coronary Disease
| Article | Year |
|---|---|
[A case of anaphylactic shock with tranexamique acid (Exacyl)].
Topics: Aged; Anaphylaxis; Antifibrinolytic Agents; Coronary Artery Bypass; Coronary Disease; Drug Hypersens | 2004 |